Bank Of America Corp Praxis Precision Medicines, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.18 $353,916 - $503,157	426,405 Added 10.59%	4,452,174 $5.12 Million
Q1 2023 May 12, 2023	BUY	$0.8 - $4.98 $2.01 Million - $12.5 Million	2,510,848 Added 165.74%	4,025,769 $3.26 Million
Q4 2022 Feb 10, 2023	BUY	$1.88 - $2.49 $2.79 Million - $3.69 Million	1,481,427 Added 4422.96%	1,514,921 $3.61 Million
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.77 $696,352 - $1.33 Million	-278,541 Reduced 89.27%	33,494 $76,000
Q2 2022 Aug 12, 2022	BUY	$1.75 - $11.34 $359,178 - $2.33 Million	205,245 Added 192.19%	312,035 $764,000

Q1 2022 May 16, 2022	BUY	$10.21 - $20.29 $147,575 - $293,271	14,454 Added 15.65%	106,790 $1.09 Million
Q4 2021 Feb 08, 2022	BUY	$16.76 - $22.99 $1.13 Million - $1.55 Million	67,315 Added 269.03%	92,336 $1.82 Million
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $141,362 - $242,520	10,750 Added 75.33%	25,021 $462,000
Q2 2021 Sep 13, 2021	BUY	$18.28 - $33.05 $260,873 - $471,656	14,271 New	14,271 $262,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $1.79B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.